Rallybio RLYB
NASDAQ RLYB
$17.20 -0.02 (-0.12%)
At close: Sep 30, 2026 · 4:00 PM EDT

Rallybio (RLYB) Revenue (2024 - 2026)

Updated

Rallybio (RLYB) recorded Revenue of $212,000 in Q1 2026, unchanged from $212,000 a year earlier and down 4.5% from the prior quarter.

Analysis

Rallybio (RLYB) Revenue (2024 - 2026) Analysis & Trends

For FY2025, Rallybio reported Revenue of $858,000, up 34.9% from FY2024.

  • Across earlier years, Revenue came in at $636,000 in FY2024.
  • Quarterly Revenue has ranged from $38,000 in Q4 2024 to $299,000 in Q3 2024 over the past five years.
  • On a year-over-year basis, Revenue rose in 1 of the last four quarters, with growth averaging 106.5%.
  • Per Business Quant, the preceding three quarters came in at $222,000 (Q4 2025), $212,000 (Q3 2025) and $212,000 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Rallybio 91.28 Mn 91.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 212,000.00
Dec 31, 2025 222,000.00
Sep 30, 2025 212,000.00
Jun 30, 2025 212,000.00
Mar 31, 2025 212,000.00
Dec 31, 2024 38,000.00
Sep 30, 2024 299,000.00
Jun 30, 2024 299,000.00
API Access

Rallybio Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=RLYB&period=max&api_key=YOUR_API_KEY